Clinical Trial Update: Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma [NA]

View source ↗

Summary

A completed trial from Zhejiang Cancer Hospital evaluating different radiation doses in neoadjuvant chemoradiotherapy for resectable thoracic esophageal squamou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy | NA | Status: COMPLETED